Antiretroviral treatment of maternal HIV infection

Haleh Talaie, Alejandro A. Nava-Ocampo, Gideon Koren

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Question. One of my pregnant patients tested positive for human immunodeficiency virus. Will HIV therapy put her pregnancy outcome at risk? Answer. The biggest risk is vertical transmission of HIV to her baby. She should be treated with combination therapy; triple therapy is required to reduce vertical transmission. Zidovudine is not teratogenic in humans, but information on other antiretroviral drugs is incomplete.

Original languageEnglish
Pages (from-to)865-868
Number of pages4
JournalCanadian Family Physician
Volume50
Issue numberJUNE
StatePublished - Jun 2004

Fingerprint

Dive into the research topics of 'Antiretroviral treatment of maternal HIV infection'. Together they form a unique fingerprint.

Cite this